Skip to main content
GSP CROP SCIENCE LIMITED logo

GSP CROP SCIENCE LIMITED — Investor Relations & Filings

Ticker · GSPCROP ISIN · INE713R01022 LEI · 3358001QPXLCP86N6O76 BSE.NS Manufacturing
Open in API
Filings indexed 56 across all filing types
Latest filing 2026-05-26 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS GSPCROP

About GSP CROP SCIENCE LIMITED

https://www.gspcrop.in/

GSP Crop Science Limited specializes in the research, development, and manufacturing of a comprehensive range of crop protection products. The company produces technical grade chemicals and diverse formulations, including insecticides, fungicides, herbicides, and plant growth regulators. Its operations are centered on integrated manufacturing facilities and dedicated research laboratories focused on developing innovative solutions for agricultural productivity. The product portfolio addresses various crop segments, providing targeted treatments for pest management and disease control. GSP Crop Science maintains an extensive distribution network, supplying its products to a global customer base. By prioritizing technical excellence and quality control, the company delivers specialized inputs designed to optimize crop yields and support sustainable farming practices.

Recent filings

Filing Released Lang Actions
Dividend
Interim / Quarterly Report Classification · 85% confidence The document is a Board Meeting outcome notice filed under SEBI Listing Regulations (Regulation 30 & 33) announcing and enclosing the company’s Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2026 along with the Independent Auditor’s Report. It includes full financial statements (Statement of Profit & Loss, Balance Sheet, Cash Flow Statement) and substantive financial data, not merely high‐level highlights. This is not a full Annual Report (10‐K) nor just an earnings teaser, but a comprehensive period‐end financial report for a portion of the fiscal year. Therefore it should be classified as an Interim/Quarterly Report. FY 2026
2026-05-26 English
Outcome of Board Meeting
Regulatory Filings Classification · 90% confidence The document is a stock‐exchange filing under SEBI Listing Regulations announcing the outcome of the Board meeting, including approval of audited annual financial results, recommendation of dividend, auditor appointments, and key managerial personnel changes. While it contains full financial statements and auditors’ reports, it is not a full Annual Report (10‐K) with MD&A, nor a typical quarterly interim report (IR) or earnings release (ER). It is a compliance/regulatory announcement under Listing Obligations and thus best fits the general “Regulatory Filings” category (RNS).
2026-05-26 English
Recommendation of dividend @10% i.e. Rs. 1/- per equity share for FY 2025-26 subject to the approval of members at the ensuing AGM.
Earnings Release Classification · 85% confidence The document is an exchange filing under SEBI Listing Regulations disclosing the audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2026, along with the independent auditor’s reports and board approvals for dividends, auditor appointments, and management changes. It constitutes the initial announcement of periodic financial results rather than a full annual report or a brief highlights-only release. Under our taxonomy, the appropriate category for a substantive financial-results announcement is Earnings Release (ER). FY 2026
2026-05-26 English
Audited Standalone and Consolidated Financial Result for the quarter and financial year ended March 31, 2026
Interim / Quarterly Report Classification · 80% confidence The document is a Board Meeting outcome notice sent to the stock exchanges under SEBI Listing Regulations 30 & 33. It primarily discloses the audited financial results (quarter and year ended March 31, 2026) along with full P&L, balance sheet and cash flow statements, auditor’s reports, dividends and related Board decisions. This is not a full Annual Report or proxy, nor merely an announcement, but the actual financial statements for the period. Therefore it fits the definition of an Interim/Quarterly Report (IR). FY 2026
2026-05-26 English
Audited - Standalone and Consolidated for Financial Results the Company for quarter and financial year ended March 31, 2026
Regulatory Filings Classification · 85% confidence The document is a board meeting outcome notice filed under SEBI Listing Regulations 30 and 33 to the stock exchanges. It contains the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, along with auditors’ reports, dividend recommendation, auditor appointments, and key management personnel changes. It is not a full Annual Report (10-K), nor merely a summary earnings release (ER), nor an interim report structured like a 10-Q/half-year report with MD&A. Instead, it is a regulatory disclosure of results and corporate decisions under Indian listing rules. Therefore, it best fits the generic Regulatory Filings category (RNS).
2026-05-26 English
GSP Crop Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve The meeting of the Board of ....
Regulatory Filings Classification · 79% confidence The document is a notice to stock exchanges under SEBI LODR Regulation 29, informing of an upcoming Board meeting to consider and approve audited financial results and a dividend recommendation. It does not contain the actual financial statements (so not an Annual or Interim Report), nor is it announcing publication of a report (so not RPA). It is a mandatory regulatory announcement, falling under the general "Regulatory Filings" category.
2026-05-20 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.